- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech High Growth Potential Companies
Australian Pharmaceuticals & Biotech High Growth Potential Companies
Results
16
1 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
16 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CUV | AU$11.35 | -1.7% | -28.7% | AU$574.4m | AU$28.23 | PE15.9x | E26.2% | 0.4% | ||
OPT | AU$1.05 | -2.8% | 84.2% | AU$1.3b | AU$1.20 | PS3099.8x | E60.4% | n/a | ||
ACR | AU$0.032 | 1.6% | -47.5% | AU$12.5m | AU$0.11 | PS2.5x | E91.8% | 0% | ||
BOT | AU$0.49 | 17.9% | 160.5% | AU$876.3m | AU$0.65 | PS436.7x | E99.4% | n/a | ||
MSB | AU$2.98 | -6.6% | 964.3% | AU$3.8b | AU$2.69 | PS402.6x | E54.9% | n/a | ||
VFY New | AU$1.46 | -10.4% | n/a | AU$93.9m | AU$2.32 | PB2.7x | E71.3% | n/a | ||
ARX | AU$0.54 | -6.1% | -6.1% | AU$182.8m | AU$0.85 | PS2.7x | E60.4% | n/a | ||
GSS | AU$0.55 | -5.2% | 12.2% | AU$119.2m | AU$1.05 | PS9.1x | E74.5% | n/a | ||
BDX | AU$0.10 | -2.4% | 19.2% | AU$37.5m | AU$0.20 | PS12.1x | E90.6% | n/a | ||
TLX | AU$27.75 | -6.2% | 141.3% | AU$9.6b | AU$25.76 | PE190.1x | E30.4% | n/a | ||
MVP | AU$0.80 | 8.8% | -10.6% | AU$93.5m | AU$3.33 | PS2.7x | E91.2% | 0% | ||
MYX | AU$5.64 | 25.3% | 2.9% | AU$472.9m | AU$6.10 | PS1.2x | E111.4% | n/a | ||
EZZ | AU$1.93 | -4.5% | 257.4% | AU$89.4m | AU$5.45 | PE13.1x | E17.9% | 1.6% | ||
TRJ | AU$0.84 | -9.2% | -27.0% | AU$128.7m | AU$1.45 | PS0.8x | E98.8% | n/a | ||
CSL | AU$256.96 | -6.1% | -9.0% | AU$130.9b | AU$327.35 | PE29.6x | E12.7% | 1.6% | ||
CYP | AU$0.26 | 10.6% | 48.6% | AU$58.6m | AU$0.83 | PS25.3x | E72.9% | n/a |
Page 1 of 1